![]() |
市场调查报告书
商品编码
1708171
内视镜市场中的人工智慧机会、成长动力、产业趋势分析及 2025 - 2034 年预测AI in Endoscopy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球内视镜人工智慧市场价值为 22 亿美元,预计 2025 年至 2034 年期间将以 25.3% 的强劲复合年增长率扩张。该市场的快速成长反映了全球胃肠道及相关疾病激增所推动的对先进诊断工具的需求不断增长。随着结肠直肠癌、发炎性肠道疾病和消化性溃疡等胃肠道疾病的发生率持续上升,医疗保健系统迫切需要提供更准确、更快速、更可靠的诊断解决方案。人工智慧内视镜正在成为一种变革性工具,它正在重塑临床医生即时检测和治疗异常的方式。人工智慧目前在提高诊断准确性、简化临床工作流程和提供预测见解方面发挥关键作用,所有这些都有助于改善患者的治疗效果。
人工智慧在内视镜检查程序中的整合使医生能够更精确地识别病变、肿瘤和息肉,显着减少人为错误并提高早期诊断率。随着全球医疗保健提供者专注于微创手术,人工智慧技术在提供增强视觉化、即时分析和自动检测方面变得至关重要,最终改善临床决策过程。人工智慧演算法的不断发展,加上高清成像和机器人辅助平台的整合,进一步推动了对基于人工智慧的内视镜解决方案的需求,使该市场成为医疗器材製造商和医疗机构关注的重点。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 22亿美元 |
预测值 | 211亿美元 |
复合年增长率 | 25.3% |
内视镜市场中的人工智慧会根据手术类型进行细分,包括胃肠道、泌尿科、呼吸科、大肠镜检查等。其中,胃肠内视镜领域占据市场主导地位,2023 年市场规模达 6.312 亿美元,主要得益于胃肠道疾病盛行率的上升。电脑辅助检测 (CADe) 系统等人工智慧解决方案正在透过精确识别息肉和肿瘤等异常情况来改变胃肠内视镜检查。采用人工智慧即时视讯分析和影像增强技术的工具正在提高诊断速度和准确性,促进更快的临床干预。这些进步正在鼓励医院和诊所采用基于人工智慧的内视镜工具作为其标准诊断协议的一部分。
从组件角度来看,市场分为人工智慧设备、软体和服务。 2024 年,人工智慧设备领域占据了 48.7% 的份额,这得益于人们对先进诊断和视觉化技术的日益增长的偏好。这些设备使医疗保健提供者能够执行更有针对性和更有效的内视镜检查,以支援更快的诊断和治疗。向微创干预的转变,加上即时人工智慧功能,正在推动紧凑、高性能内视镜工具开发的重大创新,这些工具可与人工智慧软体无缝集成,以优化结果。
从地区来看,北美在内视镜人工智慧市场中占据领先地位,2024 年的份额为 44.3%,其中美国凭藉其强大的医疗保健基础设施和早期采用人工智慧技术而占据领先地位。技术提供者和医疗机构之间正在进行的合作正在促进创新产品开发并加速市场渗透。该地区积极投资研发并专注于整合人工智慧以提高程序效率和患者护理,并继续巩固其在全球市场中的地位。
The Global AI in Endoscopy Market was valued at USD 2.2 billion in 2024 and is projected to expand at a robust CAGR of 25.3% from 2025 to 2034. The rapid growth of this market reflects the increasing demand for advanced diagnostic tools driven by a surge in gastrointestinal and related disorders worldwide. As gastrointestinal diseases, including colorectal cancer, inflammatory bowel disease, and peptic ulcers, continue to rise, healthcare systems are urgently seeking solutions that offer more accurate, faster, and reliable diagnoses. AI-powered endoscopy is emerging as a transformative tool that is reshaping how clinicians detect and treat abnormalities in real time. Artificial intelligence is now playing a pivotal role in enhancing diagnostic accuracy, streamlining clinical workflows, and delivering predictive insights, all contributing to better patient outcomes.
The integration of AI in endoscopy procedures allows physicians to identify lesions, tumors, and polyps with higher precision, significantly reducing human error and improving early diagnosis rates. With healthcare providers worldwide focusing on minimally invasive procedures, AI technologies are becoming essential in providing enhanced visualization, real-time analysis, and automated detection, ultimately improving clinical decision-making processes. The continuous evolution of AI algorithms, coupled with the integration of high-definition imaging and robotic-assisted platforms, is further driving the demand for AI-based endoscopy solutions, making this market a critical focus for medical device manufacturers and healthcare institutions alike.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $2.2 Billion |
Forecast Value | $21.1 Billion |
CAGR | 25.3% |
The AI in endoscopy market is segmented based on procedure types, including gastrointestinal, urological, respiratory, colonoscopy, and others. Among these, the gastrointestinal endoscopy segment dominated the market and generated USD 631.2 million in 2023, largely propelled by the rising prevalence of gastrointestinal conditions. AI-driven solutions such as computer-aided detection (CADe) systems are transforming gastrointestinal endoscopy by enabling precise identification of abnormalities like polyps and tumors. Tools featuring AI-powered real-time video analysis and image enhancement technologies are improving diagnostic speeds and accuracy, facilitating quicker clinical interventions. These advancements are encouraging hospitals and clinics to adopt AI-based endoscopy tools as part of their standard diagnostic protocols.
From a component perspective, the market is divided into AI-powered devices, software, and services. The AI-powered devices segment accounted for a 48.7% share in 2024, underpinned by the growing preference for advanced diagnostic and visualization technologies. These devices are enabling healthcare providers to perform more targeted and efficient endoscopic procedures, supporting faster diagnosis and treatment. The shift toward minimally invasive interventions, coupled with real-time AI capabilities, is driving significant innovations in the development of compact, high-performance endoscopic tools that integrate seamlessly with AI software for optimized outcomes.
Regionally, North America led the AI in endoscopy market with a 44.3% share in 2024, spearheaded by the U.S. due to its strong healthcare infrastructure and early adoption of AI technologies. Ongoing collaborations between technology providers and healthcare institutions are fostering innovative product development and accelerating market penetration. The region's proactive investment in R&D and focus on integrating AI to improve procedural efficiency and patient care continue to strengthen its position in the global market.